Welcome to #1 DIGITAL HEALTH NEWS Portal

Machine Learning Combines with Multispectral Infrared Imaging to Guide Cancer Surgery

Surgical tumor removal remains one of the most common procedures during cancer treatment, with about 45 percent of cancer patients undergoing surgical tumor removal at some point. Thanks to recent progress in imaging and biochemical technologies, surgeons are now better able to tell tumors apart from healthy tissue. Specifically, this is enabled by a technique called "fluorescence-guided surgery" (FGS).

Read more ...

JNM Explores Potential Applications for ChatGPT in Nuclear Medicine and Molecular Imaging

A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging. In the article, Irène Buvat, PhD, and Wolfgang Weber, MD, PhD, report on discussions they held with ChatGPT regarding several nuclear medicine and molecular imaging topics and provide their commentary on the pros and cons of using the chatbot.

Read more ...

Paper Written Using ChatGPT Demonstrates Opportunities and Challenges of AI in Academia

ChatGPT has the potential to create increasing and exciting opportunities - but also poses significant challenges - for the academic community, according to an innovative study written in large part using the software.

Launched in November 2022, ChatGPT is the latest chatbot and artificial intelligence (AI) platform touted as having the potential to revolutionise research and education.

Read more ...

AI Predicts Genetics of Cancerous Brain Tumors in under 90 Seconds

Using artificial intelligence (AI), researchers have discovered how to screen for genetic mutations in cancerous brain tumors in under 90 seconds - and possibly streamline the diagnosis and treatment of gliomas, a study suggests.

A team of neurosurgeons and engineers at Michigan Medicine, in collaboration with investigators from New York University, University of California, San Francisco and others, developed an AI-based diagnostic screening system called DeepGlioma that uses rapid imaging to analyze tumor specimens taken during an operation and detect genetic mutations more rapidly.

Read more ...

Insilico Medicine Brings AI-Powered "ChatPandaGPT" to its Target Discovery Platform

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, "ChatPandaGPT," enables researchers to have natural language conversations with the platform and efficiently navigate and analyze large datasets, facilitating the discovery of potential therapeutic targets and biomarkers in a more efficient manner.

Read more ...

BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson's Disease Clinical Trial

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG, announced a collaboration with Rune Labs and Emerald Innovations focused on using wearable and invisible contactless digital health technology to improve monitoring and data collection for Parkinson's disease clinical trials.

Read more ...

Hospital Future Act, AI, Consumer Health - Numerous Aspects of Digital Health at DMEA 2023

25 - 27 April 2023, Berlin, Germany.
The congress programme at DMEA 2023 has been announced: over the three days of the event more than 200 speakers from all over the world will present their visions of digitalisation in the healthcare system. Among those taking part will be Federal Health Minister Prof. Dr. Karl Lauterbach, Dr. Susanne Ozegowski and Dr. med. Markus Leyck Dieken.

Read more ...

Why I Keep my Mum in Mind when Designing Clinical Audit

Opinion Article by Martin Dean, System Architect, CaseCapture.
Healthcare professionals don't want to spend their time with clinical audit software. This might appear an unusual statement for someone who builds that very technology. But for me, recognising this is one of the most important parts of meeting the needs of our clinical users, and ultimately their patients.

Read more ...

Can ChatGPT be Counted On?

A study in the Journal of The National Cancer Institute Cancer Spectrum looked at chatbots and artificial intelligence (AI), as they become popular resources for cancer information. They found these resources give accurate information when asked about common cancer myths and misconceptions. In the first study of its kind, Skyler Johnson, MD, physician-scientist at Huntsman Cancer Institute and assistant professor in the department of radiation oncology at the University of Utah (the U), evaluated the reliability and accuracy of ChatGPT's cancer information.

Read more ...

NHS Patients Targeted to Reduce Risks as they Wait for Hospital Treatment

Surgeons say the NHS 'Waiting Well' initiative now has national relevance - the project has already shown improved outcomes, reduced complications and shorter stays for patients taking part, at a time when more than seven million people in England are on waiting lists.

Led by integrated care board NHS Cheshire and Merseyside, with the support of technology partner C2-Ai and health coaching provider Surgery Hero, the programme is helping to locate and provide urgently needed support for some of the most vulnerable patients awaiting surgery.

Read more ...